BofA Lowers Price Target for Medtronic (MDT) Stock
Bank of America (BofA) has implemented a reduction in its price target for Medtronic (MDT) stock. This adjustment signals a revised financial outlook from the prominent institution regarding the medical technology company's shares. The reported change reflects an updated valuation assessment by BofA, indicating a downward modification in its previous forecast for Medtronic's market performance.
Bank of America (BofA) has reportedly adjusted its financial outlook for Medtronic (MDT) stock. The firm has lowered its price target for the medical technology company's shares.
This action by BofA indicates a revised valuation assessment concerning Medtronic.
According to Yahoo Finance, the report details this downward revision in the stock's price target.

